Table II.
Mean Changes from Baseline to Study End in SeSBP by Baseline SeSBP Strata (Primary Analysis Population)
| Irbesartan/HCTZ | Irbesartan | HCTZ | ||||
|---|---|---|---|---|---|---|
| No. | Mean Change (SE), mm Hg | No. | Mean Change (SE), mm Hg | No. | Mean Change (SE), mm Hg | |
| Baseline SeSBP, mm Hg | ||||||
| 140–159 | 180 | −22.1 (0.91) | 74 | −14.3 (1.41) | ||
| 160–179 | 406 | −30.4 (0.69) | 161 | −23.2 (1.16) | ||
| >180 | 120 | −42.9 (1.68) | 56 | −30.6 (2.70) | ||
| Overall | 706 | −29.9 (0.59) | 291 | −21.7 (0.97) | 104 | −15.7 (1.53) |
| Baseline SeDBP, mm Hg | ||||||
| −Overall | 706 | −20.4 (0.38) | 291 | −17.3 (0.63) | 104 | −7.2 (0.75) |
| Abbreviations: HCTZ, hydrochlorothiazide; SeSBP, seated systolic blood pressure. | ||||||